Alignment Healthcare (ALHC) president discloses planned stock sales in Form 4 filing

Q: What insider transaction did Alignment Healthcare (ALHC) disclose in this Form 4?

The report shows that Dawn C. Maroney , president of Alignment Healthcare, sold shares of common stock in two open-market transactions on December 12 and December 15, 2025.

Q: How many Alignment Healthcare (ALHC) shares did Dawn C. Maroney sell and on what dates?

She sold 16,681 shares of common stock on 12/12/2025 and 113,319 shares on 12/15/2025 , both reported with transaction code "S" for open-market sale.

Q: What prices did Dawn C. Maroney receive for her ALHC stock sales?

The 12/12/2025 sale had a weighted-average price of $20.0204 per share, and the 12/15/2025 sale had a weighted-average price of $20.0068 per share, each based on multiple trades within narrow price ranges.

Q: How many Alignment Healthcare shares does Dawn C. Maroney own after these transactions?

After the 12/12/2025 sale, she directly owned 1,780,556 shares of common stock, and after the 12/15/2025 sale she directly owned 1,667,237 shares .

Q: What do the weighted-average prices mean in this Alignment Healthcare Form 4?

The explanations state that each reported price is a weighted-average from multiple trades, with shares sold in per-share price ranges such as $20.00 to $20.04 and $19.37 to $20.28 , and that detailed breakdowns are available upon request.

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Alignment Healthcare president Dawn C. Maroney reported open-market sales of company common stock executed under a Rule 10b5-1 trading plan adopted on 05/22/2025. On December 12, 2025, she sold 16,681 shares at a weighted-average price of $20.0204 per share, leaving 1,780,556 shares directly owned. On December 15, 2025, she sold 113,319 shares at a weighted-average price of $20.0068 per share, and directly held 1,667,237 shares afterward. For each date, the weighted-average prices reflect multiple trades within narrow price ranges disclosed in the report.

Insider Trade Summary

Net Seller: 130,000 shares ($2,601,111)

Net Sell 2 txns

Insider Maroney Dawn Christine

Role President

Sold 130,000 shs ($2.60M)

Type	Security	Shares	Price	Value
Sale	Common Stock	113,319	$20.0068	$2.27M
Sale	Common Stock	16,681	$20.0204	$334K

Holdings After Transaction: Common Stock — 1,667,237 shares (Direct)

Footnotes (1)

Date of adoption of Rule 10b5-1 plan: 05/22/2025 The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.00 to $20.04. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.37 to $20.28. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Form 4 Insider Transactions: What Each Field Means →

12/15/2025 - 06:23 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Maroney Dawn Christine

(Last)

(First)

(Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE

92868

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President

3. Date of Earliest Transaction (Month/Day/Year)
12/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	12/12/2025		S⁽¹⁾		16,681	D	$20.0204⁽²⁾	1,780,556	D
Common Stock	12/15/2025		S⁽¹⁾		113,319	D	$20.0068⁽³⁾	1,667,237	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Date of adoption of Rule 10b5-1 plan: 05/22/2025

2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.00 to $20.04. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

3. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.37 to $20.28. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Dawn C. Maroney	12/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Alignment Healthcare (ALHC) disclose in this Form 4?

The report shows that Dawn C. Maroney, president of Alignment Healthcare, sold shares of common stock in two open-market transactions on December 12 and December 15, 2025.

How many Alignment Healthcare (ALHC) shares did Dawn C. Maroney sell and on what dates?

She sold 16,681 shares of common stock on 12/12/2025 and 113,319 shares on 12/15/2025, both reported with transaction code "S" for open-market sale.

What prices did Dawn C. Maroney receive for her ALHC stock sales?

The 12/12/2025 sale had a weighted-average price of $20.0204 per share, and the 12/15/2025 sale had a weighted-average price of $20.0068 per share, each based on multiple trades within narrow price ranges.

How many Alignment Healthcare shares does Dawn C. Maroney own after these transactions?

After the 12/12/2025 sale, she directly owned 1,780,556 shares of common stock, and after the 12/15/2025 sale she directly owned 1,667,237 shares.

Were Dawn C. Maroney’s ALHC stock sales under a Rule 10b5-1 trading plan?

Yes. The report indicates the box for Rule 10b5-1 was checked and notes that the trading plan was adopted on 05/22/2025.

What do the weighted-average prices mean in this Alignment Healthcare Form 4?

The explanations state that each reported price is a weighted-average from multiple trades, with shares sold in per-share price ranges such as $20.00 to $20.04 and $19.37 to $20.28, and that detailed breakdowns are available upon request.